Composite sterilization gas generator "Biovector", nucleic acid resolution Achieved 99.99%.

Sealive. Inc.

Company website

Ehime Toyo Industrial Creative Center 2F, 2151-10 Ojoin, Niihama, Ehime 792-0060

TEL (0897) 66-1085 FAX (0897) 66-1082

Certified products and technology
Gas-phase gene (nucleic acid: DNA / RNA) Sterilization BioGas Generator by decomposition technology Biovector®
Sealive. Inc.  1

Sealive is a venture company founded in 1989. Based on electronic circuit design techniques, the company has been involved in automation and labor-saving in various production lines such as video deck production. The company’s electronic circuit design technology has also been adopted in the space sector where advanced technology is required. Engaged in electronic circuit boards for applications such as observation satellites, the company has gained a strong reputation for its technical capabilities.

On the other hand, the company began joint development with the Kyushu University School of Medicine in around 2008 for the sterilization gas generator "Biovector®" With this technology, vaporized methanol generates a composite bio-gas with a sterilizing effect by passing through a catalyst. "Because methanol is a common raw material, the running cost is low" says President Yasushi Suzuki, since complex biogas is used, it can penetrate to the inside of the sterilization target structure, and decontamination of DNA level of nucleic acid of 99.99% is possible. Also, because conventional sterilizers use formalin or peracetic acid mist for sterilization, there is a drawback that it is impossible to use electronic equipment sensitive to water, but with this device such electronic devices can be used, which is the major feature. The movable device does not need to be made hygienic, making it possible to easily install a clean room anywhere.

Sealive. Inc.  2

Now the company "must prove scientifically the sterilization effect, and guarantee safety", and is performing demonstration experiments to target a variety of viruses. For this reason the company plans to acquire sponsor companies and strengthen cooperation with research institutions that can evaluate the technology as a third party.

Sealive. Inc.  3

In the future, the company plans to aim at markets in industrial and agricultural applications. In industrial applications, the company plans to engage in production lines for recycling and nursing care products, where sterilization is required in the manufacturing process to "basically provide technical assistance". In agricultural applications, the company aims to use the technology in sterile processing of seed eggs, and has formed a consortium with the Kyushu University Faculty of Agriculture. The company wants to "Accumulate empirical data, and prove safety early on." If whole chicken houses can be sterilized it is hoped that the technology may be applied as a crisis management measure, such as for avian flu. Piling up these achievements, the company eventually plans for the technology to be utilized as infrastructure to support the most advanced medical care.

Sealive. Inc.  4

The company is also developing a transport technology using a moisture-permeable waterproof material which can keep the temperature and humidity constant for a long time without power. The company developed a moisture-permeable waterproof material with nanofibers as the main raw material. With the property that water will not pass through but gas will, it is mainly used for humidification purposes during cell culture. The company aims to apply this technology in food transport. "The ability to provide humidity at a constant temperature makes it suitable for transportation of things like fresh vegetables" he says, and will focus on early commercialization.

Download company details PDF